# AVOPEF
> **NDA220200** · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2026-02-13
## Drug
- **FDA Application Number:** NDA220200
- **Application type:** New Drug Application
- **Brand name:** AVOPEF
- **Generic name:** ETOPOSIDE
- **Active ingredients:** ETOPOSIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AVYXA HOLDINGS
- **Manufacturer:** Avyxa Pharma, LLC
- **First approval:** 2026-02-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220200)
---
*AI Analytics · CC0 1.0*